Mozifor 24 mg Injection

About Mozifor 24 mg Injection

Mozifor 24 mg Injection is a specialized stem cell mobilizer designed to enhance the collection of hematopoietic stem cells in patients undergoing treatment for conditions such as non-Hodgkin's lymphoma and multiple myeloma. This injectable medication contains Plerixafor, which belongs to a unique class of drugs known as hematopoietic stem cell mobilizers. By binding to the CXCR4 chemokine receptor, Mozifor effectively prevents the interaction with its natural ligand, CXCL12, thereby facilitating the release of stem cells into the bloodstream for easier harvesting. Typically used in conjunction with granulocyte colony-stimulating factor (G-CSF), this combination therapy optimizes the preparation of stem cells for transplantation. It is important to monitor patients for potential side effects, including injection site reactions and low blood cell counts, as these can occur during treatment. Patients should also be screened for hypersensitivity to Plerixafor prior to administration. As a critical component in the treatment of specific blood cancers, Mozifor 24 mg Injection plays a vital role in enhancing the success rates of stem cell transplants, making it a key option for patients in need of such interventions.